Recombinant anti-c-Src Nanobody, Clone # Nb76, COOH-terminal HA tag. Type: VHH single domain Source: E. Coli Applications: ELISA, Immunoprecipitation, Pull down Clonality: Monoclonal Background: c-Src VHH Antibody was produced in an llama with human recombinant Src fragment comprising amino acids 1-252 then cloned for recombinant production in E. Coli. The kinase Src is a non receptor tyrosine kinase that is activated by immune response receptors, GPCRs, and cytokine receptors. Perturbation of Src contributes to cell transformation, cancer cell invasion and metastasis, and cell cycle progression. Recombinant anti-c-Src Nanobody 76 was developed by Gulliver Biomed. |